The following list includes some of Chiesi's products that are available in the UK. Please visit http://www.medicines.org.uk/emc/ or https://www.emcmedicines.com/northernireland (NI) for more information.
Amryt Pharmaceuticals DAC is a wholly owned subsidiary of CHIESI SpA and the Marketing Authorisation Holder for (Myalepta/Lojuxta/Filsuvez) in the EU and UK.
For the UK: Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Chiesi Limited on 0800 0092329 (UK) or PV.UK@Chiesi.com.
For Ireland: Adverse events should be reported to HPRA Pharmacovigilance - www.hpra.ie. Adverse events should also be reported to Chiesi Limited on 1800 817459 (IE) or PV.UK@Chiesi.com.
GB-CHI-2400012 October 2024
SPC - Clenil® Modulite® 50mcg (with Dose Indicator)
SPC - Clenil® Modulite® 100mcg (with Dose Indicator)
SPC - Clenil® Modulite® 200mcg (with Dose Indicator)
SPC - Clenil® Modulite® 250mcg (with Dose Indicator)
PIL - Clenil® Modulite® 50mcg (with Dose Indicator)
PIL - Clenil® Modulite® 50mcg (without Dose Indicator)
PIL - Clenil® Modulite® 100mcg (with Dose Indicator)
PIL - Clenil® Modulite® 100mcg (without Dose Indicator)
PIL - Clenil® Modulite® 200mcg (with Dose Indicator)
PIL - Clenil® Modulite® 200mcg (without Dose Indicator)
PIL - Clenil® Modulite® 250mcg (with Dose Indicator)
PIL - Clenil® Modulite® 250mcg (without Dose Indicator)
